Improve Trial Readiness with Tech-Enabled FSP Delivery Models

Digitally enabled FSP models are changing how clinical trials and development programs are planned, staffed and executed across the life sciences industry. As sponsors face pressure to start studies faster, scale resources efficiently and meet critical milestones, technology is becoming an important lever for reducing operational burden while maintaining quality.

This webinar explores how FSP delivery can support faster starts, stronger operational oversight and more responsive clinical development programs. The featured speakers will discuss practical applications of technology in day-to-day FSP operations, including how digital tools can streamline workflows, improve visibility across teams and support better-informed decisions in real-world program settings.

Attendees will also gain perspective on how emerging technologies are being applied within FSP partnerships to accelerate timelines, support milestone delivery and strengthen governance. The session will address how organizations can integrate technology into FSP models effectively while balancing innovation, quality expectations and operational control.

Register for this webinar to learn how FSP delivery can reduce operational burden, accelerate decision-making and strengthen clinical development programs in 2026 and beyond.

Speakers

Craig McIlloney, Senior Vice President, Worldwide Flex, Worldwide Clinical Trials

Craig brings 25 years of experience in drug development with small and large CROs to his role with Worldwide. As Senior Vice President of Worldwide Flex, Craig is responsible for the global execution of functional services across multiple therapeutic areas.  In his previous roles Craig has overseen global operations across multiple functions, including but not limited to data management, biostatistics, statistical programming, medical writing, quality, analytics, systems and communications.  This has included global expansion across multiple regions, and his leadership experience spans activities in various delivery models, including FSP, full-service and hybrid models. He earned a BS (Hons) Degree in Statistics from the University of Glasgow, UK and an MS in Applied Statistics from Napier University, Edinburgh, UK. He is a Chartered Statistician (Cstat) with the Royal Statistical Society and was previously a Director of the Statisticians in the Pharmaceutical Industry (PSI).

Message Presenter

Stephen Rayda, Chief Digital & Information Officer, Worldwide Clinical Trials

Stephen has more than two decades of experience driving innovation in health care technology and operations. Before joining Worldwide, Stephen was EVP of Global Enterprise Systems at Syneos Health, overseeing corporate systems, enterprise architecture, infrastructure, security operations, application security and clinical/commercial operations technologies. He has been instrumental in driving transformative initiatives that modernized operations and boosted efficiency, including developing a strategic technology roadmap with the clinical team, deploying GenAI chatbot solutions for customer service and implementing multimillion-dollar cost-saving measures. Prior to Syneos Health, Stephen held roles at Mundipharma IT Services and Purdue Pharma. He earned his Bachelor’s Degree in Management with a minor in Computer Science from Frankin and Marshall College; and has refined his expertise through advanced executive education in the Chief Digital Officer program at the Kellogg School of Management.

Message Presenter

Jay Leonard, Vice President, Enterprise Technology Transformation and Architecture, Worldwide Clinical Trials

Jay is a Senior Technology Executive who operates at the intersection of enterprise strategy, business transformation and technology, ensuring that technology is not only aligned to the business, but actively shaping and accelerating it. Jay helps translate enterprise strategy into actionable technology, data and operating model direction. He is responsible for aligning enterprise architecture, technology investments and portfolio priorities to enable large-scale transformation, including post-merger integration and global growth initiatives. Jay leads Enterprise Architecture and IT Business Operations while driving the governance, prioritization and sequencing of strategic initiatives across the organization. He plays a critical role in shaping investment decisions, establishing architecture and portfolio governance frameworks, and enabling executive-level decision-making that connects strategy to measurable business outcomes.

Message Presenter